ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,850,770 | -8.9% | 171,915 | +122.3% | 0.07% | -27.3% |
Q2 2023 | $3,128,013 | +31.6% | 77,348 | +30.5% | 0.10% | +35.6% |
Q1 2023 | $2,376,968 | -99.8% | 59,276 | +196.4% | 0.07% | +170.4% |
Q1 2015 | $1,242,000,000 | +13.2% | 20,000 | -20.0% | 0.03% | +42.1% |
Q4 2014 | $1,097,000,000 | – | 25,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |